EUVIMEDEUVIMED entdecken
Leserbrief

Initial rituximab monotherapy for adult indiopathic nephrotic syndrome with minimal change lesion pattern

Ricong Xu, Haofei Hu, Hengchang Xu, Zhijian Li, Jianying Guo, Tao Cao, Yi Yu, Xiaojie Chen, Yi Xu, Qijun Wan iD

Nephrology Dialysis Transplantation · 2024

DOI: 10.1093/ndt/gfae012 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Nephrology Dialysis Transplantation, 2024. Verfasst von Ricong Xu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Nephrosis, Lipoid, Nephrotic Syndrome, Rituximab. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Basic Research Program of the Shenzhen Science and Technology R & D Fund, Shenzhen Second People's Hospital Clinical Research Fund of Guangdong Province High-level Hospital Construction Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nephrosis, LipoidNephrotic SyndromeRituximabAdultFemaleHumansMaleMiddle AgedImmunologic Factors

Substanzen

Immunologic FactorsRituximab

Autor:innen und Institutionen

  • Department of Nephrology, Shenzhen Second People's Hospital, First Affiliated Hospital of Shenzhen University, Shenzhen, Guangdong, China.
  • Department of Nephrology, Longgang Orthopedics Hospital of Shenzhen, Shenzhen, Guangdong, China.
  • Department of Nephrology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

ORCID-Profile: Qijun Wan

Förderung

  • National Natural Science Foundation of China
  • Basic Research Program of the Shenzhen Science and Technology R & D Fund
  • Shenzhen Second People's Hospital Clinical Research Fund of Guangdong Province High-level Hospital Construction Project
  • Shenzhen Key Medical Discipline Construction Fund

Zitieren

APA

Xu, R., Hu, H., Xu, H., Li, Z., Guo, J., Cao, T., Yu, Y., Chen, X., Xu, Y., & Wan, Q. (2024). Initial rituximab monotherapy for adult indiopathic nephrotic syndrome with minimal change lesion pattern. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfae012

Vancouver

Xu R, Hu H, Xu H, Li Z, Guo J, Cao T, et al. Initial rituximab monotherapy for adult indiopathic nephrotic syndrome with minimal change lesion pattern. Nephrology Dialysis Transplantation. 2024. doi:10.1093/ndt/gfae012

BibTeX
@article{Xu2024,
  author = {Xu, Ricong and Hu, Haofei and Xu, Hengchang and Li, Zhijian and Guo, Jianying and Cao, Tao and Yu, Yi and Chen, Xiaojie and Xu, Yi and Wan, Qijun},
  title = {Initial rituximab monotherapy for adult indiopathic nephrotic syndrome with minimal change lesion pattern},
  journal = {Nephrology Dialysis Transplantation},
  year = {2024},
  doi = {10.1093/ndt/gfae012}
}
Kostenlos starten →